ConductScience.org, home

Paper76519

The alpha2-plasmin inhibitor levels in liver diseases.

Aoki N and 1 other. Clin Chim Acta, 1978. Cited by 95 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The alpha2-plasmin inhibitor levels in liver diseases. Papers, record 76519. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/76519

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The alpha2-plasmin inhibitor levels in liver diseases.
PubMed
Journal
Clin Chim Acta
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
95
iCite
Relative citation ratio, by iCite
3.43
iCite
Revised in PubMed
2019-07-06
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Aoki NN
2Yamanaka TT

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood ProteinsMajor topic
FibrinolysinMajor topic
Liver DiseasesMajor topic
Adult
Female
Humans
Liver Cirrhosis
Male
alpha 1-Antitrypsin
alpha-Macroglobulins

Source PubMed

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 95 citations.

PMIDTitleJournalYearIn PapersSource
39,628,652Enhanced thrombin and plasmin generation profiles in alpha-2-antiplasmin-deficient patients: Data from the Rare Bleeding disorders in the Netherlands study.Res Pract Thromb Haemost2024https://conductscience.org/library/papers/39628652PubMed
36,452,200Plasmin Inhibitor in Health and Diabetes: Role of the Protein as a Therapeutic Target.TH Open2022https://conductscience.org/library/papers/36452200PubMed
34,830,419Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics.Int J Mol Sci2021https://conductscience.org/library/papers/34830419PubMed
30,271,063Emergent Neurosurgical Management of a Rapidly Deteriorating Patient with Acute Intracranial Hemorrhage and Alcohol-Related Thrombocytopenia.J Neurosci Rural Pract2018https://conductscience.org/library/papers/30271063PubMed
21,415,961Viral cirrhosis: an overview of haemostatic alterations and clinical consequences.Mediterr J Hematol Infect Dis2009https://conductscience.org/library/papers/21415961PubMed
9,038,736Hyperfibrinolysis in hepatosplenic schistosomiasis.J Clin Pathol1996https://conductscience.org/library/papers/9038736PubMed
7,199,538Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.J Clin Invest1982https://conductscience.org/library/papers/7199538PubMed
6,852,439Usefulness of antithrombin III and alpha 2-plasmin inhibitor in early differentiation of fulminant hepatitis and severe form of acute hepatitis.Gastroenterol Jpn1983https://conductscience.org/library/papers/6852439PubMed
6,479,679Antithrombin III, plasminogen and alpha 2 antiplasmin in jaundice. Clinical usefulness and prognostic significance.Gut1984https://conductscience.org/library/papers/6479679PubMed
6,444,305Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.J Clin Invest1980https://conductscience.org/library/papers/6444305PubMed
6,291,058Synthesis and secretion of alpha 2-plasmin inhibitor by established human liver cell lines.Proc Natl Acad Sci U S A1982https://conductscience.org/library/papers/6291058PubMed
6,235,248Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator.J Clin Pathol1984https://conductscience.org/library/papers/6235248PubMed
6,085,504Profiles of acute-phase reactants and clinical significance of alpha 2-macroglobulin in acute hepatitis B.Inflammation1983https://conductscience.org/library/papers/6085504PubMed
3,493,701Extravascular plasminogen activator and inhibitor activities detected at the site of a chronic mycobacterial-induced inflammation.Am J Pathol1987https://conductscience.org/library/papers/3493701PubMed
3,296,855Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation.Anesthesiology1987https://conductscience.org/library/papers/3296855PubMed
2,526,671Clinical disorders of fibrinolysis: a critical review.Blut1989https://conductscience.org/library/papers/2526671PubMed
156,196Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency.J Clin Invest1979https://conductscience.org/library/papers/156196PubMed

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
A2M2PubTator's text mininghttps://conductscience.org/library/genes/2NCBI Gene
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
BCHE590PubTator's text mininghttps://conductscience.org/library/genes/590NCBI Gene
PLG5,340PubTator's text mininghttps://conductscience.org/library/genes/5340NCBI Gene
SERPINA15,265PubTator's text mininghttps://conductscience.org/library/genes/5265NCBI Gene
SERPINF25,345PubTator's text mininghttps://conductscience.org/library/genes/5345NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/76519

GET https://conductscience.org/api/papers/v1/76519/authors